Ghost Tree Capital, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.59 - $4.3 $1.23 Million - $2.04 Million	-473,562 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.78 - $5.32 $1.63 Million - $2.29 Million	-430,663 Reduced 47.63%	473,562 $1.8 Million
Q1 2021 May 14, 2021	BUY	$4.57 - $7.18 $3.22 Million - $5.06 Million	704,225 Added 352.11%	904,225 $5.14 Million
Q3 2020 Nov 16, 2020	SELL	$3.85 - $28.47 $539,000 - $3.99 Million	-140,000 Reduced 41.18%	200,000 $778,000
Q2 2020 Aug 14, 2020	BUY	$16.01 - $34.69 $3.6 Million - $7.81 Million	225,000 Added 195.65%	340,000 $9.78 Million
Q1 2020 May 15, 2020	BUY	$14.53 - $30.69 $1.67 Million - $3.53 Million	115,000 New	115,000 $2.48 Million

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.